CNS Drug-Maker Reviva Announces $18M Public Offering of Common Stock and Warrants to Fund R&D

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) has announced plans for a public offering of common stock (or its equivalents)...
16 hours ago
from: GeneOnline

Nasdaq, Public offering, Stock market, Warrant

More about this

- Reviva Pharmaceuticals Shares Slide Premarket After Stock Offering
By Colin Kellaher. Shares of Reviva Pharmaceuticals Holdings tumbled in premarket trading Tuesday after the pharmaceutical company said it...
from: MarketWatch

- Reviva Pharmaceuticals Announces $18M Public Offering with Warrant Package to Fund R&D Pipeline
Reviva Pharmaceuticals secures fresh capital through a strategic offering of 12M shares and warrants, earmarking funds for research...
from: Stock Titan

- Reviva announces pricing of $18M public offering of common stock and warrants
Reviva Pharmaceuticals (NASDAQ:RVPH) announced the pricing of an underwritten public offering of 12M shares together with series A warrants...
from: MSN

- Reviva Announces Proposed Public Offering
CUPERTINO, Calif., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a...
from: GlobeNewswire